|1.||Johns, Edward James: 2 articles (01/2009 - 02/2008)|
|2.||Khan, Md Abdul Hye: 2 articles (01/2009 - 02/2008)|
|3.||Abdullah, Nor Azizan: 2 articles (01/2009 - 02/2008)|
|4.||Swarup, K R L Anand: 1 article (01/2009)|
|5.||Hussain, Nurjannah M: 1 article (01/2009)|
|6.||Sattar, Munavvar Abdul: 1 article (01/2009)|
|7.||Kazi, Raisa N: 1 article (01/2009)|
|8.||Dewa, Aidiahmad: 1 article (01/2009)|
|9.||Basri, Fathihah: 1 article (01/2009)|
|10.||Abdulla, Mohammed H: 1 article (01/2009)|
06/01/2001 - "Additionally, we examined the effects of CGP 41251, WB-4101 (alpha1a -adrenoceptor antagonist), chloroethylclonidine (CEC) (alpha1b-adrenoceptor antagonist) and selective damage of endocardial endothelium by Triton X-100 on the protection against hypoxia induced by preconditioning of rat heart tissue. "
12/29/1995 - "These results suggest the alpha1-adrenoceptor subtype blocked by chloroethylclonidine, but not that blocked by WB4101, is capable of increasing the incidence of lethal arrhythmias that occur at rapid atrial rates during ischemia."
05/01/1994 - "Phenylephrine effects on Rsl in simulated ischemia were studied in the absence or presence of the alpha 1-subtype blockers WB 4101 (WB) or chloroethylclonidine (CEC), both 0.1 mumol/L, and in Purkinje fibers from dogs injected with pertussis toxin (PTX) (30 micrograms/kg i.v., 60 to 72 hours before study). "
|3.||Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
10/01/1993 - "We have used radioligand binding and inositol phosphate accumulation studies to determine the affinity at mixed alpha 1A- and alpha 1B-adrenoceptors (rat cerebral cortex and kidney), alpha 1A-adrenoceptors (rat cerebral cortex and kidney following inactivation of alpha 1B-adrenoceptors by chloroethylclonidine treatment) and alpha 1B-adrenoceptors (rat spleen) for drugs currently under investigation for the treatment of benign prostatic hypertrophy, alfuzosin, naftopidil and (-)- and (+)-tamsulosin. "
10/08/1997 - "Chloroethylclonidine and alpha-adrenoceptor agonist interaction in blood vessels following heart failure."
10/08/1997 - "This study examined the interaction of chloroethylclonidine with alpha-adrenoceptor agonists in canine endothelium-denuded dorsal pedal artery and saphenous vein before (non-paced) and at end-stage heart failure which was induced by rapid ventricular pacing (250 bpm for no more than four weeks). "
10/08/1997 - "In contrast, in the saphenous vein, chloroethylclonidine (at all concentrations tested) inhibited the response to phenylephrine in non-paced dogs, whereas the inhibitory effect was not as marked in heart failure. "
10/08/1997 - "In the dorsal pedal artery, chloroethylclonidine (10(-4) M) potentiated low concentrations and inhibited higher concentrations of phenylephrine from non-paced animals but had no significant effect at heart failure. "
10/08/1997 - "In the saphenous vein, chloroethylclonidine (10(-6) and 10(-5) M) potentiated the response to methoxamine from non-paced dogs but did not significantly effect the response at heart failure. "
12/29/1995 - "Phenylephrine infusion in the stroke-prone spontaneously hypertensive rats caused changes in renal haemodynamics and fluid excretion of comparable magnitude to that achieved in Wistars which was blocked by 5-methylurapidil but not chloroethylclonidine. "
07/01/1995 - "The effects of noradrenaline (NA) on the perfusion pressure of mesenteric vascular bed preparations from stroke-prone spontaneously hypertensive rats (SHRSP) or weight-matched normotensive Wistar-Kyoto (WKY) rats in the presence of chloroethylclonidine (CEC, alpha 1B-adrenoceptor antagonist) or WB4101 (WB, alpha 1A-adrenoceptor antagonist), with or without the addition of nifedipine, were studied. "
|1.||(2- (2',6'- dimethoxy)phenoxyethylamino)methylbenzo- 1,4- dioxane
|2.||Octoxynol (Triton X 100)
|6.||Adrenergic Receptors (Adrenergic Receptor)